Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for INTEGRIS Southwest Medical Center located at 4401 S Western Ave, Oklahoma City, OK, 73109 & includes data from NPIs 1457372625, 1538587464, 1336252717
Dexur analyzed Q1 2018 (January to March 2018) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for INTEGRIS Southwest Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Jan 2018 to Mar 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,211 | 1,126 | ||||||||||
| Surgical | 249 | 236 | ||||||||||
| Non Surgical | 962 | 890 | ||||||||||
| General Medicine | 235 | 206 | ||||||||||
| Cardiovascular | 176 | 163 | ||||||||||
| Pulmonology | 172 | 166 | ||||||||||
| Orthopedics | 151 | 146 | ||||||||||
| Neurology | 144 | 133 | ||||||||||
| Gastroenterology & Endocrinology | 111 | 105 | ||||||||||
| General Surgery | 86 | 76 | ||||||||||
| Urology | 76 | 73 | ||||||||||
| Oncology & Hematology | 27 | 25 |
| Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Jan 2018 to Mar 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare | ||||||||||||
| DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Signs And Symptoms | ||||||||||||
| DRG 947: SIGNS AND SYMPTOMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders |
| Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Jan 2018 to Mar 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization |
| Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Jan 2018 to Mar 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Respiratory System Diagnosis With Ventilator Support |
| Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Jan 2018 to Mar 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 561: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 559: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity |
| Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Jan 2018 to Mar 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 056: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| Seizures |
| Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Jan 2018 to Mar 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Jan 2018 to Mar 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jan 2018 to Mar 2018) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Oklahoma Total Hospitalizations (Jan 2018 to Mar 2018) | Oklahoma Total Hospitalizations After Exclusion | Oklahoma Total Users | Oklahoma SNF Discharge Rate (%) | National Total Hospitalizations (Jan 2018 to Mar 2018) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections |